859 reports of this reaction
3.4% of all EPLERENONE reports
#4 most reported adverse reaction
HYPOTENSION is the #4 most commonly reported adverse reaction for EPLERENONE, manufactured by Viatris Specialty LLC. There are 859 FDA adverse event reports linking EPLERENONE to HYPOTENSION. This represents approximately 3.4% of all 25,060 adverse event reports for this drug.
Patients taking EPLERENONE who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among EPLERENONE users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for EPLERENONE:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 859 FDA reports for EPLERENONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.4% of all adverse event reports for EPLERENONE, making it a notable side effect.
If you experience hypotension while taking EPLERENONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.